Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03404609 · ClinicalTrials.gov registry record · NA
Rapid Non-Invasive Brain Stimulation for OCD (oTMS)
A NA study of OCD, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT03404609: Completed NA study of OCD, sponsored by Stanford University.
NCT03404609 is a NA study of OCD that has completed, run by Stanford University. The registered enrollment target is 7 participants, below the 818-participant average among 18 other OCD trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03404609, a NA study of OCD, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand how cortical stimulation affects Obsessive-Compulsive Disorder (OCD) symptoms.
Primary Outcome
Patients given YBOCS (Yale Brown Obsessive-Compulsive Scale), a gold standard measure of obsessions and compulsions. For the YBOCS the minimum units are 0 and Maximum units on the total scale are 40. The higher the number on the YBOCS, the more severe the symptoms. Response was defined as at least a 35% reduction on the YBOCS.
Conditions Studied
Interventions
- DEVICE MagPro X100 by MagVenture
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-08-25 |
| Est. Completion | 2019-07-01 |
| Phase | NA |
What the finished NCT03404609 record still lists
NCT03404609 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 818-participant average among 18 other OCD trials with a reported enrollment target (99% lower).
The record links to 1 condition, with OCD appearing as the primary indexed condition, and to 1 intervention - of which MagPro X100 by MagVenture is the first listed.
NCT03404609 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03404609 about?
NCT03404609 is a clinical study titled "Rapid Non-Invasive Brain Stimulation for OCD (oTMS)". The purpose of this study is to understand how cortical stimulation affects Obsessive-Compulsive Disorder (OCD) symptoms.
What is the current status of trial NCT03404609?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2018-08-25. Estimated completion is 2019-07-01.
What conditions does trial NCT03404609 study?
This clinical trial studies the following conditions: OCD.
What interventions are being tested in trial NCT03404609?
The interventions under investigation include: MagPro X100 by MagVenture (DEVICE).
Who is sponsoring clinical trial NCT03404609?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03404609 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for OCD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03404609's enrollment target sits among peer trials
7 19th of 18 the lowest of 18 other OCD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other OCD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation for a Novel OCD Biomarker and Treatment
RECRUITING · NA
-
Personalized DBS for OCD Guided by Stereoencephalography Mapping
RECRUITING · NA
-
Neurostimulation Versus Therapy for Problems With Emotions
RECRUITING · NA
-
How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD
RECRUITING · NA
-
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
RECRUITING · NA
-
Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI